Low-density lipoprotein susceptibility to oxidation and cytotoxicity to endothelium in sickle cell anemia

J Lab Clin Med. 1999 Jun;133(6):605-12. doi: 10.1016/s0022-2143(99)90191-9.

Abstract

Patients with sickle-cell anemia exhibit pro-oxidative metabolic perturbations. We hypothesize that because of chronic oxidative stress, plasma low-density lipoprotein (LDL) from patients with sickle-cell anemia is more susceptible to oxidation. To test this hypothesis, LDL susceptibility to copper-mediated oxidation was measured in 24 patients with sickle-cell anemia and 48 control subjects. Sickle-cell LDL was more susceptible to oxidation than control LDL, measured by a 22% shorter mean lag time between LDL exposure to CuSO4 and conjugated diene formation (97 vs 124 minutes; P = .023). LDL vitamin E, iron, heme, and cholesterol ester hydroperoxide (CEOOH) levels were also measured. LDL vitamin E levels were significantly lower in patients with sickle-cell anemia compared with control subjects (1.8 vs 2.9 mol/mol LDL; P = .025), but there was no correlation with lag time. Pro-oxidant heme and iron levels were the same in sickle-cell and control LDL. LDL CEOOHs were not significantly different in sickle and control LDL (3.1 vs 1.2 mmol/mol of LDL unesterified cholesterol, P = .15), but LDL CEOOH levels were inversely correlated with lag times in patients with sickle-cell anemia (r2 = 0.38; P = .018). The cytotoxicity of partially oxidized LDL to porcine aortic endothelial cells was inversely correlated with lag times (r2 = 0.48; P = .001). These preliminary data suggest that increased LDL susceptibility to oxidation could be a marker of oxidant stress and vasculopathy in patients with sickle-cell anemia.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Anemia, Sickle Cell / metabolism*
  • Animals
  • Aorta / drug effects
  • Aorta / pathology
  • Child
  • Child, Preschool
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / pathology*
  • Heme / metabolism
  • Humans
  • In Vitro Techniques
  • Iron / metabolism
  • Lipid Peroxidation*
  • Lipoproteins, LDL / metabolism*
  • Lipoproteins, LDL / pharmacology
  • Middle Aged
  • Oxidation-Reduction
  • Swine
  • Time Factors

Substances

  • Lipoproteins, LDL
  • oxidized low density lipoprotein
  • Heme
  • Iron